The 2-Minute Rule for Milademetan
Other clinical trials in individuals with non-Hodgkin's lymphoma [24] and patients with Superior malignancy [14] have shown also that zosuquidar didn't appreciably affect the pharmacokinetics of doxorubicin and experienced reasonable results within the pharmacokinetics of vincristine. These clinical trials authorized that zosuquidar could safely ad